Prosperity Investor logo
"Health Care Singularity" is here...
This newsletter led by Dr. David Eifrig and John Engel explores the huge opportunity as the health care sector and technology take off over the coming years... Through investing, becoming better health care consumers, and improving our overall health...
Sign up for a Trial Subscription to Prosperity Investor

About Prosperity Investor

Prosperity Investor is a monthly advisory that shows readers how to unlock massive possible gains in health care investing.

Led by Dr. David Eifrig and John Engel, this newsletter focuses on investments that will provide opportunities to create generational wealth and to improve the quality and length of our lives.

These experts believe that the decade ahead of us – the age of "Health Care Singularity" – will revolutionize the way we manage our No. 1 asset – our health. And they have the credentials to back it up.

Health care companies embracing this same view are coming out of the woodwork and driving change today. The options available to us over the next 10 years will drastically improve our lives... They could even extend our lifespan by 25 years or more.

Current and future medical technology will be deployed across the spectrum of care. And with the U.S. population growing older, the need for health care is only going to explode. The time to invest in this sector is now.

Portfolio Snapshot
Number of Positions
20 - 30 investment ideas.
Safety

Lower

Higher

*Number of positions, safety, and returns may vary. These are estimates based upon our track record and historical data.
Publication Overview
How often is this service published?
Monthly
How much capital should I have to get started?
$10,000
What will we be buying?
Equities
Do you put on short trades?
No
What's a typical holding period?
3-5 years but will depend on each recommendation
Dr. David Eifrig
Editor
Dr. David Eifrig
John Engel
Analyst
John Engel
Jeff Havenstein
Senior Analyst
Jeff Havenstein
About The Editor

Dr. David Eifrig, MD, MBA, is the ideal editor for a health care-focused advisory like Prosperity Investor. He began his career by trading derivatives at Goldman Sachs, where he worked for more than a decade.

In 1995, he decided to change paths and left Wall Street to pursue medicine. He graduated from Columbia University’s post-baccalaureate pre-medicine program and later earned his MD with clinical honors from the University of North Carolina at Chapel Hill.

Dr. Eifrig also completed a research fellowship in molecular genetics at Duke University and became a board-eligible eye surgeon.

Get instant access in just a few simple steps
Back to Top